These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 28042936)
1. Effect of type 2 diabetes mellitus on the pharmacokinetics and transplacental transfer of nifedipine in hypertensive pregnant women. Filgueira GCO; Filgueira OAS; Carvalho DM; Marques MP; Moisés ECD; Duarte G; Lanchote VL; Cavalli RC Br J Clin Pharmacol; 2017 Jul; 83(7):1571-1579. PubMed ID: 28042936 [TBL] [Abstract][Full Text] [Related]
2. A Pilot Study of the Maternal-Fetal Pharmacokinetics of Furosemide in Plasma, Urine, and Amniotic Fluid of Hypertensive Parturient Women Under Cesarean Section. Gonçalves PVB; Moreira FL; Benzi JRL; Duarte G; Lanchote VL J Clin Pharmacol; 2020 Dec; 60(12):1655-1661. PubMed ID: 32562572 [TBL] [Abstract][Full Text] [Related]
3. Analysis of nifedipine in human plasma and amniotic fluid by liquid chromatography-tandem mass spectrometry and its application to clinical pharmacokinetics in hypertensive pregnant women. Filgueira GC; Filgueira OA; Carvalho DM; Marques MP; Moisés EC; Duarte G; Lanchote VL; Cavalli RC J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Jul; 993-994():20-5. PubMed ID: 25984962 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of nifedipine slow-release during sustained tocolysis. ter Laak MA; Roos C; Touw DJ; van Hattum PR; Kwee A; Lotgering FK; Mol BW; van Pampus MG; Porath MM; Spaanderman ME; van der Post JA; Papatsonis DN; van 't Veer NE Int J Clin Pharmacol Ther; 2015 Jan; 53(1):84-91. PubMed ID: 25407260 [TBL] [Abstract][Full Text] [Related]
5. Can oral contraceptive steroids influence the elimination of nifedipine and its primary pryidine metabolite in humans? Balogh A; Gessinger S; Svarovsky U; Hippius M; Mellinger U; Klinger G; Hoffmann A; Oettel M Eur J Clin Pharmacol; 1998; 54(9-10):729-34. PubMed ID: 9923576 [TBL] [Abstract][Full Text] [Related]
6. Decreased placental and transcellular permeation of cefuroxime in pregnant women with diabetes. Lalic-Popovic M; Paunkovic J; Grujic Z; Golocorbin-Kon S; Milasinovic L; Al-Salami H; Mikov M J Diabetes; 2016 Mar; 8(2):238-45. PubMed ID: 25800069 [TBL] [Abstract][Full Text] [Related]
7. Nifedipine concentrations in maternal and umbilical serum, amniotic fluid, breast milk and urine of mothers and offspring. Manninen AK; Juhakoski A Int J Clin Pharmacol Res; 1991; 11(5):231-6. PubMed ID: 1814844 [TBL] [Abstract][Full Text] [Related]
8. Transplacental Distribution of Lidocaine and Its Metabolite in Peridural Anesthesia Administered to Patients With Gestational Diabetes Mellitus. Moises EC; Duarte Lde B; Cavalli Rde C; Carvalho DM; Filgueira GC; Marques MP; Lanchote VL; Duarte G Reprod Sci; 2015 Jul; 22(7):791-7. PubMed ID: 25563756 [TBL] [Abstract][Full Text] [Related]
11. Effects of HMG-CoA reductase inhibitors on the pharmacokinetics of nifedipine in rats: Possible role of P-gp and CYP3A4 inhibition by HMG-CoA reductase inhibitors. Lee CK; Choi JS; Choi DH Pharmacol Rep; 2015 Feb; 67(1):44-51. PubMed ID: 25560574 [TBL] [Abstract][Full Text] [Related]
12. Effects of pioglitazone on the pharmacokinetics of nifedipine and its main metabolite, dehydronifedipine, in rats. Choi JS; Choi I; Choi DH Eur J Drug Metab Pharmacokinet; 2016 Jun; 41(3):231-8. PubMed ID: 25549928 [TBL] [Abstract][Full Text] [Related]
13. Placental transfer and perinatal pharmacokinetics of betaxolol. Morselli PL; Boutroy MJ; Bianchetti G; Zipfel A; Boutroy JL; Vert P Eur J Clin Pharmacol; 1990; 38(5):477-83. PubMed ID: 2379532 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic modelling of the placental transfer of nelfinavir and its M8 metabolite: a population study using 75 maternal-cord plasma samples. Hirt D; Urien S; Jullien V; Firtion G; Chappuy H; Rey E; Pons G; Mandelbrot L; Treluyer JM Br J Clin Pharmacol; 2007 Nov; 64(5):634-44. PubMed ID: 17892516 [TBL] [Abstract][Full Text] [Related]
15. Bupropion therapy during pregnancy: the drug and its major metabolites in umbilical cord plasma and amniotic fluid. Fokina VM; West H; Oncken C; Clark SM; Ahmed MS; Hankins GD; Nanovskaya TN Am J Obstet Gynecol; 2016 Oct; 215(4):497.e1-7. PubMed ID: 27180885 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic and Tolerability Comparison of Sustained and Immediate Release Oral Formulations of Nifedipine Tablet Formulations: A Single-Dose, Randomized, Open-Label, Two-Period, Two-Way Crossover Study in Healthy, Fasting Egyptian Male Volunteers. El-Masry SM; El-Khodary NM Drug Res (Stuttg); 2020 Feb; 70(2-03):91-96. PubMed ID: 31746448 [TBL] [Abstract][Full Text] [Related]
17. Effects of nifedipine on the pharmacokinetics of repaglinide in rats: possible role of CYP3A4 and P-glycoprotein inhibition by nifedipine. Choi JS; Choi I; Choi DH Pharmacol Rep; 2013; 65(5):1422-30. PubMed ID: 24399740 [TBL] [Abstract][Full Text] [Related]
18. Effect of type 2 diabetes mellitus on the pharmacokinetics of metformin in obese pregnant women. de Oliveira Baraldi C; Moisés EC; de Jesus Ponte Carvalho TM; de Jesus Antunes N; Lanchote VL; Duarte G; Cavalli RC Clin Pharmacokinet; 2012 Nov; 51(11):743-9. PubMed ID: 23018469 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of nifedipine in Taiwanese. Chien SC; Uang YS; Lin HY; Hsu KY Biopharm Drug Dispos; 2004 Mar; 25(2):77-84. PubMed ID: 14872555 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic and pharmacodynamic differences between nifedipine capsule and GITS formulations in hypertensive patients. Isordia I; Carrasco M; Chávez-Negrete A; Palma-Aguirre JA; Flores-Murrieta FJ; Castañeda-Hernández G Int J Clin Pharmacol Ther; 1997 Mar; 35(3):133. PubMed ID: 9089004 [No Abstract] [Full Text] [Related] [Next] [New Search]